FDA Issues Recall On Clinical Specialties Products Due To Contamination Risks

March 22nd, 2013 | Drug injury

March 22, 2013 The U.S. Food and Drug Administration (FDA) has partnered with drug manufacturer, Clinical Specialties, in voluntarily recalling doses of several medications that were packaged by the company and are potentially contaminated. On Monday, the agency issued a press release that announced the recall of more than 40 lots of the drug Avastin® that had been repackaged… Read More